Pelthos Therapeutics Inc. (PTHS) SEC filings
PTHS SEC filings moved a median of -1.55% by the close. PTHS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PTHS overview →
34 measured PTHS SEC filing events.
Where these PTHS SEC filings landedvs 31 measured PTHS SEC filing reactions
| Middle 50% of PTHS SEC filing reactions | -3.17% to +2.56% |
|---|---|
| Median reaction (to close) | -1.55% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 PTHS SEC filing events with a measured close landed between -3.17% and +2.56%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form ARS Pelthos Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.53% | -2.90% | |
| Form DEF 14A Pelthos Therapeutics For: Sep 29 | SEC filing · Form DEF | +0.53% | -2.90% | |
| Form DEFA14A Pelthos Therapeutics | SEC filing · Form DEFA14A | +0.53% | -2.90% | |
| Form 10-Q Pelthos Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +5.83% | +4.14% | |
| Form 10-Q/A Pelthos Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +5.83% | +4.14% | |
| Form 8-K Pelthos Therapeutics For: Aug 12 | SEC filing · Form 8-K | +5.83% | +4.14% | |
| Form 8-K Pelthos Therapeutics For: Aug 13 | SEC filing · Form 8-K | +5.83% | +4.14% | |
| Form PRE 14A Pelthos Therapeutics For: Sep 29 | SEC filing · Form PRE | — | — | |
| Form 8-K Pelthos Therapeutics For: May 28 | SEC filing · Form 8-K | — | +1.46% | |
| Form 8-K Pelthos Therapeutics For: May 15 | SEC filing · Form 8-K | — | -1.55% | |
| Form 10-Q Pelthos Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +1.85% | +2.56% | |
| Form 8-K Pelthos Therapeutics For: May 14 | SEC filing · Form 8-K | +1.85% | +2.56% | |
| Form 8-K Pelthos Therapeutics For: Apr 14 | SEC filing · Form 8-K | +0.00% | -1.96% | |
| Form 8-K Pelthos Therapeutics For: Apr 10 | SEC filing · Form 8-K | — | +2.77% | |
| Form 10-K Pelthos Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -7.95% | |
| Form 8-K Pelthos Therapeutics For: Mar 19 | SEC filing · Form 8-K | +0.00% | -7.95% | |
| Form EFFECT Pelthos Therapeutics | SEC filing · Form EFFECT | -2.23% | +2.34% | |
| Form S-3 Pelthos Therapeutics | SEC filing · Form S-3 | — | -6.97% | |
| Form 8-K Pelthos Therapeutics For: Jan 12 | SEC filing · Form 8-K | — | -3.17% | |
| Form 8-K Pelthos Therapeutics For: Jan 06 | SEC filing · Form 8-K | — | -3.17% | |
| Form 8-K Pelthos Therapeutics For: Dec 23 | SEC filing · Form 8-K | -6.97% | -2.26% | |
| Form 8-K Pelthos Therapeutics For: Dec 23 | SEC filing · Form 8-K | +0.00% | +2.20% | |
| Form 8-K Pelthos Therapeutics For: Dec 17 | SEC filing · Form 8-K | — | +2.90% | |
| Form ARS Pelthos Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.00% | -5.74% | |
| Form DEF 14A Pelthos Therapeutics For: Dec 17 | SEC filing · Form DEF | +0.00% | -3.69% | |
| Form D Pelthos Therapeutics | SEC filing · Form D | — | -5.42% | |
| Form PRE 14A Pelthos Therapeutics For: Nov 14 | SEC filing · Form PRE | +0.00% | +0.76% | |
| Form 10-Q Pelthos Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form 8-K Pelthos Therapeutics For: Nov 13 | SEC filing · Form 8-K | +0.00% | — | |
| Form 8-K Pelthos Therapeutics For: Nov 07 | SEC filing · Form 8-K | -4.01% | -7.38% | |
| Form 8-K Pelthos Therapeutics For: Oct 14 | SEC filing · Form 8-K | — | +15.63% | |
| Form EFFECT Pelthos Therapeutics | SEC filing · Form EFFECT | — | +0.30% | |
| Form S-3/A Pelthos Therapeutics | SEC filing · Form S-3 | — | -1.75% | |
| Form 8-K/A Pelthos Therapeutics For: Sep 16 | SEC filing · Form 8-K | +0.00% | +2.16% |
Keep exploring
More PTHS: earnings → · analyst actions → · PTHS overview →